PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97094515 |
Filing Date: 10/27/2021 |
Input Field |
Entered |
SERIAL NUMBER | 97094515 |
---|---|
MARK INFORMATION | |
*MARK | MEDICINES FOR LIFE |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | MEDICINES FOR LIFE |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | UNITED THERAPEUTICS CORPORATION |
*MAILING ADDRESS | 1040 SPRING STREET |
*CITY | SILVER SPRING |
*STATE (Required for U.S. applicants) |
Maryland |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
20910 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | Pharmaceutical drug development services |
FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 11/00/1997 |
FIRST USE IN COMMERCE DATE | At least as early as 11/00/1997 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPE0-1-20487401-202110011 24940867462_._Class42spec imen1.pdf |
CONVERTED PDF FILE(S) (1 page) |
\\TICRS\EXPORT18\IMAGEOUT 18\970\945\97094515\xml1\ APP0003.JPG |
ORIGINAL PDF FILE | SPE0-1-20487401-202110011 24940867462_._Class42spec imen2.pdf |
CONVERTED PDF FILE(S) (4 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\970\945\97094515\xml1\ APP0004.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\970\945\97094515\xml1\ APP0005.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\970\945\97094515\xml1\ APP0006.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\970\945\97094515\xml1\ APP0007.JPG | |
SPECIMEN DESCRIPTION | page from LinkedIn and pages from website |
WEBPAGE URL | linkedin.com/company/unitedtherapeutics |
WEBPAGE DATE OF ACCESS | 10/01/2021 |
WEBPAGE URL | unither.com |
WEBPAGE DATE OF ACCESS | 10/01/2021 |
ADDITIONAL STATEMENTS SECTION | |
ACTIVE PRIOR REGISTRATION(S) | The applicant claims ownership of active prior U.S. Registration Number(s) 2501024. |
ATTORNEY INFORMATION | |
NAME | Norm J. Rich |
ATTORNEY DOCKET NUMBER | 080618-2029 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Foley & Lardner LLP |
INTERNAL ADDRESS | Sixth Floor |
STREET | 3000 K Street, N.W. |
CITY | Washington |
STATE | District of Columbia |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 20008 |
PHONE | 202-672-5300 |
FAX | 202-672-5399 |
EMAIL ADDRESS | IPDocketing@foley.com |
OTHER APPOINTED ATTORNEY | all other attorneys of Foley & Lardner LLP |
CORRESPONDENCE INFORMATION | |
NAME | Norm J. Rich |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | IPDocketing@foley.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | nrich@foley.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /Shaun R Snader/ |
SIGNATORY'S NAME | Shaun R. Snader |
SIGNATORY'S POSITION | Vice President, Associate General Counsel, IP |
SIGNATORY'S PHONE NUMBER | 2023041701 |
DATE SIGNED | 10/26/2021 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97094515 |
Filing Date: 10/27/2021 |
The applicant's current Correspondence Information: |
Norm J. Rich |
PRIMARY EMAIL FOR CORRESPONDENCE: IPDocketing@foley.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): nrich@foley.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|